Table 1 Baseline characteristics of patients at enrollment
From: Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality
Number of patients | 142 |
|---|---|
Patient sex | Men: 90 (63.4%) |
Women: 52 (36.6%) | |
Patient age (median, years) | 58 |
Range (years) | 20–77 |
Median MELD score | 12 |
Range | 6–40 |
Etiology of liver disease (including multiple nominations) | |
- Alcoholic | 89 (62.7%) |
- Cryptogenic | 19 (13.4%) |
- Viral | 9 (6.3%) |
- NASH | 9 (6.3%) |
- Autoimmune hepatitis | 6 (4.2%) |
- PBC/PSC | 2 (1.4%) |
- Hepatocellular carcinoma | 11 (7.7%) |
Cholesterol ester | |
Median (Range) [mg/dl] | 154.3 (7.7–310.6) |
Median (Range) [mmol/l] | 3.98 (0.20–8.01) |
Total cholesterol | |
Median (Range) [mg/dl] | 210.8 (41.3–493.7) |
Median (Range) [mmol/l] | 5.44 (1.07–12.74) |
Cholesterol esterification fraction (median (Range)) | 73% (19–80%) |